Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$147K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 7 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| Mar 2 | KPTI | Karyopharm Therapeutics… | SSELL | 12,361 | $9.41 | $116.3K | -4.4% | Open the original filing on SEC.gov |
| Feb 5 | KPTI | Karyopharm Therapeutics… | AGRANT | 81,060 | — | — | +40.9% | Open the original filing on SEC.gov |
| Oct 15, 2025 | KPTI | Karyopharm Therapeutics… | AGRANT | 114,285 | — | — | +136.0% | Open the original filing on SEC.gov |
| Sep 15, 2025 | KPTI | Karyopharm Therapeutics… | SSELL | 1,257 | $6.43 | $8.1K | -1.5% | Open the original filing on SEC.gov |
| Sep 12, 2025 | KPTI | Karyopharm Therapeutics… | AGRANT | 2,800 | — | — | +3.4% | Open the original filing on SEC.gov |
| Jun 2, 2025 | BLUE | bluebird bio, Inc. | DTOISS | 1,323 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 30, 2025 | BLUE | bluebird bio, Inc. | UTENDR | 155 | — | — | -10.5% | Open the original filing on SEC.gov |
| May 6, 2025 | KPTI | Karyopharm Therapeutics… | SSELL | 236 | $7.12 | $1.7K | -0.3% | Open the original filing on SEC.gov |